Stay updated with breaking news from Query Get. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apellis Pharmaceuticals submitted a new drug application to the FDA for intravitreal pegcetacoplan, a targeted C3 therapy for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release.The submission is based on the results of the phase 3 DERBY and OAKS studies, as well as the phase 2 FILLY study. Pegcetacoplan demonstrated reduction in
Elevating the rheumatology’s profile to policymakers, medical students and patients through advocacy and education is critical for the specialty’s future, according to EULAR President Annamaria Iagnocco, MD.“EULAR is 75 years old but looks much younger,” Iagnocco said in her opening remarks of the EULAR 2022 Congress. “The past is what we know and serves as a
Among patients with cryptogenic stroke, ipsilateral complicated carotid artery plaque detected by MRI was associated with elevated risk for recurrent ischemic stroke or transient ischemic attack, data show.“To our knowledge, there are no studies that have related the presence of complicated carotid artery plaques or intraplaque hemorrhage as assessed in the first days after stroke to
Children with asthma were not at increased risk for SARS-CoV-2 infection when compared with children without asthma, a study reported.
The FDA has cleared a next-generation integrated continuous glucose monitor for people with diabetes aged 4 years and older, according to a press release from Abbott. The FreeStyle Libre 3 is the CGM with the lowest overall mean absolute relative difference in glucose on the market, as well as the smallest and thinnest sensor developed to date, according to the release.